RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TEDESCHI A
Collezione AO Cuneo

Items : 3

How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2022 Aug;63(8):1985-1988. doi: 10.1080/10428194.2022.2053532. Epub 2022 Mar 27.

2022
AO Cuneo
AOU Città della Salute di Torino

Tedeschi A; Montillo M; Zamprogna G; Marinoni S; Ferrario A; Tani M; Varettoni M; Borella C; Ferrarini I; Sanna A; Motta M; Ibatici A; Orsucci L; Massaia M; Vitale C; Vanazzi A; Mauro FR; Quaresmini G; Visentin A; Reda G; Murru R; Laurenti L; Sportoletti P; Frustaci AM; Deodato M;

JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy. in Journal of clinical medicine / J Clin Med. 2021 Aug 23;10(16):3752. doi: 10.3390/jcm10163752.

2021
AO Cuneo
ASL Alessandria
AOU San Luigi di Orbassano

Tedeschi A; Festuccia MB; Monforte AD; Capochiani E; Selleri C; Simonetti F; Saracino A; Rapezzi D; Badagliacca MR; Falasca K; Molteni A; Palazzolo R; Schettino G; Bocchia M; Turrini M; Ascierto PA; Paley C; Saglio G; Coco P; D'Alessio A; Zuurman M; Morelli M; Mortara A; Vannucchi AM;

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. in Haematologica / Haematologica. 2014 Sep;99(9):e159-61. doi: 10.3324/haematol.2014.106740. Epub 2014 Jun 27.

2014
AO Cuneo

Montillo M; Tedeschi A; Gaidano G; Coscia M; Petrizzi VB; Orlandi E; Cascavilla N; Ghia P; Motta M; Gallamini A; Frustaci AM; Rossi D; De Paoli L; Nichelatti M; Morra E; Massaia M;